SF Healthcare Week: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year
BiotechTV - News
00:00
Preclinical microRNA124 knockout study update
Marc says the microRNA124 knockout mouse study is ongoing and results are expected in coming months.
Play episode from 08:21
Transcript
